Fuji Pharma Co., Ltd. (TYO:4554)
Japan · Delayed Price · Currency is JPY 2,250.00
-12.00 (-0.53%)
At close: Feb 13, 2026
Fuji Pharma Market Cap
Fuji Pharma has a market cap or net worth of 55.35 billion as of February 13, 2026. Its market cap has increased by 55.83% in one year.
Market Cap
55.35B
Enterprise Value
82.43B
Revenue
54.57B
Ranking
n/a
PE Ratio
23.69
Stock Price
2,250.00
Market Cap Chart
Since December 21, 2005, Fuji Pharma's market cap has increased from 17.38B to 55.35B, an increase of 218.39%. That is a compound annual growth rate of 5.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 12, 2026 | 55.35B | 19.88% |
| Dec 30, 2025 | 46.17B | 18.77% |
| Dec 30, 2024 | 38.88B | -8.01% |
| Dec 29, 2023 | 42.26B | 70.05% |
| Dec 30, 2022 | 24.85B | -0.36% |
| Dec 30, 2021 | 24.94B | -35.65% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Towa Pharmaceutical | 186.57B |
| Kaken Pharmaceutical | 159.80B |
| Mochida Pharmaceutical | 132.76B |
| Zeria Pharmaceutical | 97.55B |
| KYORIN Pharmaceutical | 95.94B |
| ASKA Pharmaceutical Holdings | 69.09B |
| Daito Pharmaceutical | 40.06B |
| Koa Shoji Holdings | 35.51B |